Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Acetaminophen Interferent Evaluation of the Biolinq MicroArray Intradermal Continuous Glucose Biowearable System

NCT06560177 is registered in ClinicalTrials.gov with Biolinq Inc. as lead sponsor.

NCT NCT06560177
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06560177 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Acetaminophen Interferent Evaluation of the Biolinq MicroArray Intradermal Continuous Glucose Biowearable System
Lead sponsor
Biolinq Inc.
Phase
Not applicable
Overall status
Completed
Start date
September 10, 2024
Completion date
September 27, 2024
Enrollment
31 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, diabetes mellitus